iBio (IBIO) Intangibles (2011 - 2026)
iBio (IBIO) posted quarterly Intangibles of $1.8 million for Q1 2026, up 422.86% year-over-year from $350000.0 in Q1 2025, and down 26.89% quarter-over-quarter from $2.5 million in Q4 2025.
iBio (IBIO) Intangibles (2011 - 2026) Analysis & Trends
iBio (IBIO) has reported Intangibles for 16 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Intangibles rose 422.86% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 422.86% YoY), while the FY2025 annual figure was $6.8 million, up 27.57% from the prior year.
- Intangibles slipped to $1.8 million in Q1 2026 per IBIO's latest filing, from $2.5 million in the prior quarter.
- Across five years, Intangibles topped out at $6.8 million in Q2 2025 and bottomed at $350000.0 in Q1 2025.
- Historically, Intangibles has averaged $3.7 million across 5 years, with a median of $5.0 million in 2023.
- Annual changes were most pronounced in 2023 — Intangibles jumped 1166.58% — and 2024, when it sank 92.9%.
- iBio's Intangibles stood at $395000.0 in 2022, then surged by 1166.58% to $5.0 million in 2023, then tumbled by 92.9% to $355000.0 in 2024, then jumped by 605.07% to $2.5 million in 2025, then fell by 26.89% to $1.8 million in 2026.
- Business Quant data shows IBIO's Intangibles at $1.8 million in Q1 2026, $2.5 million in Q4 2025, and $6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | 1.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.83 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 6.84 Mn |
| Jun 30, 2025 | 6.85 Mn |
| Mar 31, 2025 | 350,000.00 |
| Dec 31, 2024 | 355,000.00 |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 5.37 Mn |
| Mar 31, 2024 | 370,000.00 |
| Dec 31, 2023 | 5.00 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 5.39 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | 395,000.00 |
| Sep 30, 2022 | 6.01 Mn |
| Jun 30, 2022 | 676,000.00 |
| Mar 31, 2022 | 4.92 Mn |
| Dec 31, 2021 | 5.04 Mn |
| Sep 30, 2021 | 5.16 Mn |
| Jun 30, 2021 | 952,000.00 |